BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19010235)

  • 61. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?
    De Carlis L; Giacomoni A; Lauterio A; Slim A; Sammartino C; Pirotta V; Colella G; Forti D
    Transpl Int; 2003 Feb; 16(2):115-22. PubMed ID: 12595973
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Hiraoka A; Horiike N; Yamashita Y; Koizumi Y; Doi H; Yamamoto Y; Ichikawa S; Hasebe A; Yano M; Miyamoto Y; Ninomiya T; Ootani H; Takamura K; Kawasaki H; Otomi Y; Kogame M; Sogabe I; Ishimaru Y; Kashihara K; Miyagawa M; Hirooka M; Hiasa Y; Matsuura B; Michitaka K; Onji M
    Hepatogastroenterology; 2009; 56(89):213-7. PubMed ID: 19453060
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liver transplantation and tacrolimus monotherapy for hepatocellular carcinoma with expanded criteria.
    Dalgic A; Karakayali H; Moray G; Emiroglu R; Sozen H; Torgay A; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3154-6. PubMed ID: 16213334
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Indications and management of everolimus after liver transplantation.
    Bilbao I; Sapisochin G; Dopazo C; Lazaro JL; Pou L; Castells L; Caralt M; Blanco L; Gantxegi A; Margarit C; Charco R
    Transplant Proc; 2009; 41(6):2172-6. PubMed ID: 19715864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
    Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
    Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma.
    Baccarani U; Isola M; Adani GL; Benzoni E; Avellini C; Lorenzin D; Bresadola F; Uzzau A; Risaliti A; Beltrami AP; Soldano F; De Anna D; Bresadola V
    Transpl Int; 2008 Mar; 21(3):247-54. PubMed ID: 18028264
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment before liver transplantation for HCC.
    Belghiti J; Carr BI; Greig PD; Lencioni R; Poon RT
    Ann Surg Oncol; 2008 Apr; 15(4):993-1000. PubMed ID: 18236111
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk.
    Kothary N; Weintraub JL; Susman J; Rundback JH
    J Vasc Interv Radiol; 2007 Dec; 18(12):1517-26; quiz 1527. PubMed ID: 18057286
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
    Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
    Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Current treatment of hepatocellular carcinoma. Analysis of a series of 123 cases over a 5-year period].
    Popescu I; Ionescu M; Ciurea S; Braşoveanu V; Sârbu-Boeţi P; Hrehoreţ D; Tomulescu V; Alexandrescu S; Dorobanţu B; Grigorie R; Jemna C; Gheorghe L; Anghel R; Croitoru A; Herlea V; Boroş M
    Chirurgia (Bucur); 2005; 100(4):321-31. PubMed ID: 16238194
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Undetected hepatocellular carcinoma in patients undergoing liver transplantation: is associated with favorable outcome.
    Urahashi T; Lynch SV; Kim YH; Balderson GA; Fawcett JW; Crawford DH; Strong RW
    Hepatogastroenterology; 2007 Jun; 54(76):1192-5. PubMed ID: 17629068
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization.
    Kobayashi A; Takahashi S; Ishii H; Konishi M; Nakagohri T; Gotohda N; Satake M; Furuse J; Kinoshita T
    Eur J Surg Oncol; 2007 Oct; 33(8):1019-24. PubMed ID: 17399939
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.
    D'Amico F; Schwartz M; Vitale A; Tabrizian P; Roayaie S; Thung S; Guido M; del Rio Martin J; Schiano T; Cillo U
    Liver Transpl; 2009 Oct; 15(10):1278-87. PubMed ID: 19790142
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation.
    Majeed TA; Wai CT; Rajekar H; Lee KH; Wong SY; Leong SO; Singh R; Tay KH; Chen J; Tan KC
    Transplant Proc; 2008 Oct; 40(8):2507-9. PubMed ID: 18929781
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
    Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J
    Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expanded criteria for hepatocellular carcinoma and liver transplantation.
    Haberal M; Emiroglu R; Karakayali H; Moray G; Yilmaz U; Ozçay F; Bilezikci B; Arslan G
    Int Surg; 2007; 92(2):110-5. PubMed ID: 17518254
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.
    Pérez-Saborido B; de los Galanes SJ; Menéu-Díaz JC; Romero CJ; Elola-Olaso AM; Suárez YF; Valencia VB; Moreno-González E
    Transplant Proc; 2007 Sep; 39(7):2304-7. PubMed ID: 17889172
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Very late recurrence of hepatocellular carcinoma after liver transplantation: case report and literature review.
    Schreibman IR; Bejarano P; Martinez EJ; Regev A
    Transplant Proc; 2006 Nov; 38(9):3140-3. PubMed ID: 17112921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.